| Pathway complexities of protein misfolding in neurodegenerative diseases: a novel approach to risk evaluation and model development (REfraME) | |||
| Program: | H2020-EU.3.1, Ref No.: 643417 | ||
| Project Coordinator: | Giuseppe Legname, SISSA, Trieste, Italy | ||
| Duration: | Jan 1, 2015 – Dec 31, 2018 | ||
Participating investigators:
|
 |
||
| SyDAD Synaptic Dysfunction in Alzheimer Disease | ||
| Program: | H2020-EU.1.3.1., Ref No.: 676144 | |
| Project Coordinator: | Bengt Winblad, KAROLINSKA INSTITUTET, Sweden | |
| Duration: | Nov 1, 2015 – Oct 31, 2019 | |
 |
||
| Repetitive Subconcussive Head Impacts -Brain Alterations and Clinical Consequences | ||
| Program: | ERANET | |
| Project Coordinator: | Inga Katharina Koerte, MD PhD, Ludwig-Maximilians-Universität München, Department of Child and Adolescent Psychiatry, Psychosomatics, Germany | |
| Project Co-investigator: | Assoc. Prof. Peter Filipcik, RNDr, PhD | |
| Duration: | January 1, 2017 – 31 December 2019 | |
 |
||
| – | |
| Non-globular proteins in the era of Machine Learning | |
| Program: | COST |
| Project leader: | Ing. Cehlár Ondrej, PhD. |
| Duration: | 1.10.2022 – 31.10.2026 |
| A premotor disease signature for ALS | |
| premodiALS – Rukopis pre-motorického štádia amytrofnej laterálnej sklerózy | |
| Program: | Horizon 2020 |
| Project leader: | doc. MVDr. Žilka Norbert, DrSc. |
| Duration: | 1.9.2022 – 31.8.2025 |
| Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs | |
| INTERTAU – Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs | |
| Program: | Horizon 2020 |
| Project leader: | RNDr. Škrabana Rostislav, PhD. |
| Duration: | 1.6.2022 – 30.6.2025 |
| Developing novel nanopharmaceutics against bacterial infections at center nervous system | |
| Antineuropatho – Vývoj nových nanoliečiv proti bakteriálnym infekciám v centrálnom nervovom systéme | |
| Program: | ERANET |
| Project leader: | doc. MVDr. Bhide Mangesh Ramesh, PhD. |
| Duration: | 1.1.2022 – 31.12.2024 |